KYLE SUTHERLAND: Open Payments
NPI 1295331791 · CLEARFIELD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 39 payments from 11 companies in 2025. Trend: 2023 $525 · 2024 $488 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $249 |
| PFIZER INC. | 7 | $207 |
| Exact Sciences Corporation | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $27 |
| Boston Scientific Corporation | 1 | $21 |
| Novo Nordisk Inc | 1 | $21 |
Products named: UBRELVY, NURTEC ODT, Cologuard Collection Kit, QULIPTA, VOQUEZNA, XIFAXAN, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
